Connectyx Technologies Holdings Group, Inc. Announces Strategic Relationship with Mid-Atlantic BioTherapeutics, Inc. for Treatment of Symptomatic Rabies

NEXT STORY
FOMO CORP. Agrees to Buy Purge Virus
PREV STORY
Oncology Pharma Announces Extension of Letter of Intent with Kalos Therapeutics, Retained an Interim CEO and Approval of Reverse Stock Split
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Consistente bevindingen inzake veiligheid en langdurige werkzaamheid na behandeling van reumapatiënten met filgotinib na 84 weken in DARWIN 3 studie

Galapagos presenteert data uit DARWIN 3, andere filgotinibstudies en GLPG1972 van Galapagos op de ...

author_avatar
NASDAQ Market News

National Cancer Institute selects Apexian Pharmaceuticals to participate in the Small Business Innovation Research (SBIR) Initiative program

Indianapolis, Indiana, USA, Sept. 27, 2017 (GLOBE NEWSWIRE) --                                                                                                                                           FOR IMMEDIATE RELEASE National ...

author_avatar
NASDAQ Market News

Global RNA Based Therapeutics Market Worth Reach USD 1.97 Billion By 2025: Zion Market Research

author_avatar
NASDAQ Market News